These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7563589)

  • 1. Ofloxacin concentrations in serum, saliva and pleural effusion of patients with pulmonary tuberculosis and lung cancer.
    Miya T; Hamakubo S; Goya T; Hanaoka T; Hosaka K
    Jpn J Antibiot; 1995 Jul; 48(7):960-4. PubMed ID: 7563589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ofloxacin penetration into tuberculous pleural effusion.
    Yew WW; Lee J; Chan CY; Cheung SW; Wong PC; Kwan SY
    Antimicrob Agents Chemother; 1991 Oct; 35(10):2159-60. PubMed ID: 1759841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the identification of biomarkers for non-small cell lung cancer in serum and pleural effusion.
    Rodríguez-Piñeiro AM; Blanco-Prieto S; Sánchez-Otero N; Rodríguez-Berrocal FJ; de la Cadena MP
    J Proteomics; 2010 Jun; 73(8):1511-22. PubMed ID: 20230924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secretion of ofloxacin into saliva in patients with respiratory tract infection.
    Takagi K; Hasegawa T; Yamaki K; Suzuki K; Nabeshima T
    Int J Clin Pharmacol Ther Toxicol; 1992 Feb; 30(2):46-50. PubMed ID: 1551745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diffusion of ofloxacin (OFLX) into prostatic tissue in patients with benign prostatic hypertrophy].
    Uchibayashi T; Nagano K; Shoda R; Hisazumi H; Sawaki M; Yamaguchi K; Kawaguchi K; Komatsu K; Kobashi K; Koizumi H
    Hinyokika Kiyo; 1990 Jun; 36(6):741-5. PubMed ID: 1700587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrapulmonary pharmacokinetics of ofloxacin in drug-resistant tuberculosis.
    Chierakul N; Klomsawat D; Chulavatnatol S; Chindavijak B
    Int J Tuberc Lung Dis; 2001 Mar; 5(3):278-82. PubMed ID: 11326828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacokinetic study of ofloxacin using saliva concentration in chronic renal failure].
    Tsubakihara Y; Hayashi T; Shoji T; Kitamura E; Okada N; Nakanishi I
    Nihon Jinzo Gakkai Shi; 1994 Mar; 36(3):246-9. PubMed ID: 8196221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ofloxacin concentration in human benign prostatic tissue after oral administration.
    Asakawa M; Yasumoto R
    Hinyokika Kiyo; 1988 Jun; 34(6):1097-9. PubMed ID: 2464915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Excretion of ofloxacin into saliva in rats with renal failure.
    Ding G; Naora K; Nagasako S; Hirano H; Iwamoto K
    J Pharmacol Exp Ther; 1998 Oct; 287(1):31-6. PubMed ID: 9765318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of CYFRA21-1, Scc-Ag and telomerase activity in serum and pleural effusion of patients with squamous-cell lung cancer.
    Liu L; Liu B; Zhu LL; Zhang W; Li Y
    Bioanalysis; 2012 Oct; 4(19):2367-74. PubMed ID: 23088463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Determination of isoniazide concentration in pleural effusion and its pleural permeability in patients with tuberculous pleurisy].
    Liu Y; Zhang Q; Zhang J; Huang G; Zhu S; Liu S; Li G
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 May; 32(5):673-6. PubMed ID: 22588922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A potential role for nitric oxide pathway in tuberculous pleural effusion.
    Elgün S; Kaçmaz B; Durak I
    Int J Tuberc Lung Dis; 2005 Mar; 9(3):339-43. PubMed ID: 15786901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunological assay of the CA-125 value in pleural effusion in various types of pleuritis--its application as a differential diagnostic parameter of tuberculous or carcinomatous pleuritis].
    Mitsutake Y; Hiromatsu Y; Saisho M; Tokunaga N; Ichikawa Y; Kaji M; Irie K
    Gan No Rinsho; 1986 May; 32(5):453-7. PubMed ID: 3459902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of ofloxacin--measurement of drug concentration in saliva of patients with impaired renal function.
    Fujita K; Matsuoka N; Takenaka I; Hiraishi K; Yokota T; Asahi T; Tatara K; Yuasa M; Kaifu Y; Kawano A
    Drugs; 1995; 49 Suppl 2():312-3. PubMed ID: 8549345
    [No Abstract]   [Full Text] [Related]  

  • 15. [Significance of detecting E-selectin of serum and pleural effusion in differentiating benign and malignant diseases].
    Liu G; Li C; Zhong X
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Sep; 21(9):556-8. PubMed ID: 11360510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteome screening of pleural effusions identifies IL1A as a diagnostic biomarker for non-small cell lung cancer.
    Li Y; Lian H; Jia Q; Wan Y
    Biochem Biophys Res Commun; 2015 Feb; 457(2):177-82. PubMed ID: 25554695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Status of lipid peroxidation and antioxidant enzymes in malignant (bronchogenic carcinoma) and non-malignant pleural effusions.
    Vanisree AJ; Shyamaladevi CS
    Indian J Cancer; 1999; 36(2-4):127-34. PubMed ID: 10921216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxygen and carbon dioxide tensions and the pH of pleural effusion.
    Kokkola K; Sahlström K; Vuorio M
    Scand J Respir Dis Suppl; 1974; 89():195-200. PubMed ID: 4528666
    [No Abstract]   [Full Text] [Related]  

  • 19. [A case of tuberculous pleurisy with a rapid decrease in pleural effusion].
    Tokuyasu H; Watanabe E; Okazaki R; Touge H; Kawasaki Y; Isowa N; Eiji S
    Nihon Kokyuki Gakkai Zasshi; 2007 Nov; 45(11):884-9. PubMed ID: 18051793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a new inflammatory molecule (triggering receptor expressed on myeloid cells-1) in the diagnosis of pleural effusion.
    Chan MC; Chang KM; Chao WC; Lin LY; Kuo BI; Hsu JY; Wu CL
    Respirology; 2007 May; 12(3):333-8. PubMed ID: 17539835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.